Pre-treatment with cardamonin protects against cisplatin-induced nephrotoxicity in rats: Impact on NOX-1, inflammation and apoptosis

被引:89
作者
El-Naga, Reem N. [1 ]
机构
[1] Ain Shams Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt
关键词
Cisplatin; Nephrotoxicity; Cardamonin; Inflammation; Apoptosis; NOX-1; PROXIMAL TUBULAR CELLS; RENAL OXIDATIVE STRESS; NADPH OXIDASES; L-ARGININE; INJURY; INHIBITION; PLATINUM; METABOLISM; MECHANISMS; BLOCKADE;
D O I
10.1016/j.taap.2013.10.031
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cisplatin is an effective anti-cancer drug; however, its clinical use is usually associated with nephrotoxicity as a dose-limiting side effect. Several molecular mechanisms have been found to be involved in this nephrotoxicity such as oxidative stress, inflammation and apoptosis. The aim of this study was to explore the potential nephroprotective effect of cardamonin, a flavone found in Alpinia plant, in a rat model of cisplatin-induced nephrotoxicity. The possible mechanisms underlying this nephroprotective effect were investigated. Cardamonin was given at two different doses; 10 and 30 mg/kg orally for two weeks, starting one week before giving a single nephrotoxic dose of cisplatin (7 mg/kg). Acute nephrtoxicity was evident by significantly increased blood urea nitrogen and serum creatinine levels. Also, cisplatin increased lipid peroxidation and depleted reduced glutathione level and superoxide dismutase. Additionally, cisplatin showed a marked pro-inflammatory response as evidenced by significant increase in tissue levels of IL-beta, TNF-alpha, NF-kB, iNOS, ICAM-1 and MCP-1. Pre-treatment with cardamonin significantly attenuated the nephrotoxic effects, oxidative stress and inflammation induced by cisplatin, in a dose-dependent manner. Also, cardamonin decreased caspase-3 expression and Bax/Bcl-2 ratio as compared to cisplatin group. Besides, cradamonin reversed cisplatin-induced decrease in EGF. Furthermore, up-regulation of NOX-1 was found to be involved in cisplatin-induced nephrotoxicity and its expression was significantly reduced by cardamonin. Histopathological examination further confirmed the nephroprotective effect of cardamonin. Moreover, pre-treatment with subtoxic concentration of cardamonin has significantly enhanced cisplatin cytotoxic activity in four different human cancer cell lines; hela, hepG2, PC3 and HCT116 cancer cell lines. In conclusion, these findings suggest that cardamonin improves therapeutic index of cisplatin and that NOX-1 is partially involved in the pathogenesis of cispaltin-induced nephrotoxicity. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:87 / 95
页数:9
相关论文
共 55 条
[1]   Cisplatin nephrotoxicity [J].
Arany, I ;
Safirstein, RL .
SEMINARS IN NEPHROLOGY, 2003, 23 (05) :460-464
[2]   Glycyrrhizic acid: A phytochemical with a protective role against cisplatin-induced genotoxicity and nephrotoxicity [J].
Arjumand, Wani ;
Sultana, Sarwat .
LIFE SCIENCES, 2011, 89 (13-14) :422-429
[3]  
Banchroft JD, 1996, THEORY PRACTICE HIST
[4]   The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology [J].
Bedard, Karen ;
Krause, Karl-Heinz .
PHYSIOLOGICAL REVIEWS, 2007, 87 (01) :245-313
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]  
CARPENTER G, 1990, J BIOL CHEM, V265, P7709
[7]   CARVEDILOL PROTECTS AGAINST APOPTOTIC CELL DEATH INDUCED BY CISPLATIN IN RENAL TUBULAR EPITHELIAL CELLS [J].
Carvalho Rodrigues, M. A. ;
Gobe, G. ;
Santos, N. A. G. ;
Santos, A. C. .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2012, 75 (16-17) :981-990
[8]   Selective iNOS inhibition reduces renal damage induced by cisplatin [J].
Chirino, Yolanda I. ;
Trujillo, Joyce ;
Javier Sanchez-Gonzalez, Dolores ;
Maria Martinez-Martinez, Claudia ;
Cruz, Cristino ;
Bobadilla, Norma A. ;
Pedraza-Chaverri, Jose .
TOXICOLOGY LETTERS, 2008, 176 (01) :48-57
[9]   Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer [J].
Cullen, Kevin J. ;
Yang, Zejia ;
Schumaker, Lisa ;
Guo, Zhongmin .
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2007, 39 (01) :43-50
[10]  
Davis CA, 2001, J AM SOC NEPHROL, V12, P2683, DOI 10.1681/ASN.V12122683